trastuzumab,fulvestrant,tucatinib
seagen
['sgntuc-019', 'trastuzumab,(-trastuzumab deruxtecan),(-trastuzumab-deruxtecan)', 'tucatinib']
sgntuc-019 phii basket of tucatinib + trastuzumab for pretreated w/&gt;1 prior line #her2+ adv btc confirmed orr 46.7% (1 cr, 13 prs), dor 6 mos, and median os 15.5 mos #asco23 
Medical oncologist and researcher in gastrointestinal and genitourinary cancers @CedarsSinai. Hematology/Oncology fellowship @cityofhope